Cargando…
Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics
Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally, representing approximately a third of all deaths every year. The greater part of these cases is represented by myocardial infarction (MI), or heart attack as it is better known, which occurs when declining bloo...
Autores principales: | Ozaki Tan, Sho Joseph, Floriano, Juliana Ferreria, Nicastro, Laura, Emanueli, Costanza, Catapano, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277090/ https://www.ncbi.nlm.nih.gov/pubmed/32370160 http://dx.doi.org/10.3390/biom10050707 |
Ejemplares similares
-
Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis
por: Tikhomirov, Roman, et al.
Publicado: (2020) -
The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction
por: Wang, Xianyun, et al.
Publicado: (2021) -
Therapeutic Potential of Exosomes Derived From circRNA_0002113 Lacking Mesenchymal Stem Cells in Myocardial Infarction
por: Tian, Tiantian, et al.
Publicado: (2022) -
Exosomes Could Offer New Options to Combat the Long-Term Complications Inflicted by Gestational Diabetes Mellitus
por: Floriano, Juliana Ferreira, et al.
Publicado: (2020) -
Exosomes in Diabetic Cardiomyopathy: The Next-Generation Therapeutic Targets?
por: Sahoo, Susmita, et al.
Publicado: (2016)